Antineoplastic/chemotherapy or immunosuppressive drugs, adverse effect: Difference between revisions
Ttenbergen (talk | contribs) No edit summary |
No edit summary |
||
(44 intermediate revisions by 7 users not shown) | |||
Line 1: | Line 1: | ||
{{ICD10 transition status | {{ICD10 transition status | ||
| OldDxArticle =Pancytopenia| CurrentStatus = | | OldDxArticle =Pancytopenia | ||
| InitialEditorAssigned = | | CurrentStatus = reconciled | ||
| InitialEditorAssigned = not assigned | |||
}} | }} | ||
{{ICD10 dx | {{ICD10 dx | ||
| MinimumCombinedCodes = | |||
| ICD10 Code=Y43.3 | | ICD10 Code=Y43.3 | ||
| BugRequired= | | BugRequired= | ||
}} | }} | ||
{{ICD10 category|Iatrogenic}}{{ICD10 category|Adverse effect}}{{ICD10 category|Allergy}}{{ICD10 category|Neoplastic}} | |||
== Additional Info == | == Additional Info == | ||
'''Includes:''' | |||
* Antirejection drugs | |||
* Side effects such as nausea/vomiting | |||
* Differentiation syndrome- Differentiation syndrome is a group of severe reactions to drugs used to treat acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL), both of which are a type of leukemia, or blood cancer. If it is thought to be in part because of an immune system disorder, link that with it. | |||
== Alternate ICD10s to consider coding instead == | |||
{{List of immunosuppressive drugs}} | |||
{ | {{ICD10 Guideline adverse effect}} | ||
== Alternate ICD10s to consider coding instead or in addition == | |||
{{ListICD10Category | categoryName = Adverse effect}} | |||
{{ListICD10Category | categoryName = Overdose}} | |||
* [[Tumor lysis syndrome]] | |||
* [[Anaphylactic reaction (anaphylaxis)]] | |||
== Candidate [[Combined ICD10 codes]] == | == Candidate [[Combined ICD10 codes]] == | ||
== Related CCI Codes == | |||
{{Data Integrity Check List}} | |||
== Related Articles == | == Related Articles == | ||
{{Related Articles}} | {{Related Articles}} | ||
{{ICD10 footer}} | |||
{{EndPlaceHolder}} |